Select Page
Event info
Date:19 Jun
Time:08:30 - 11:00
Venue:Medicon Valley Alliance, Copenhagen

SIGN UP

Contact person
Mia Ritterband-Rosenbaum

Mia Ritterband-Rosenbaum

Event Manager & PA to CEO

mrr@mva.org

+45 21 63 38 88

A Strategic CDMO Approach in Drug Development and Commercialization

Medicon Valley Alliance and Fareva would like to welcome you to a Good Morning Meeting.

Navigating the path from drug discovery to bringing a product to market is riddled with challenges, from unforeseen hurdles in chemical development to complexities in manufacturing the final drug product. The journey is not only financially demanding but also lengthy and intricate.
Beginning with the initial stages of drug discovery, progressing through clinical trials and regulatory approvals, and culminating in pre- and post-launch activities, pharmaceutical companies encounter a myriad of obstacles and uncertainties. As clinical phases advance, the demands intensify, requiring a holistic approach for a successful product launch.
At FAREVA, we draw upon our wealth of experience to address these challenges, constantly refining our strategies to offer tailored solutions for our clients. We invite you to join us as we share valuable insights and real-world case studies, providing a deeper understanding of our expertise in our upcoming discussions.

 

Date: Wednesday 19th of June 2024
Time: 8:30 – 11:00
Venue: Medicon Valley Alliance, Arne Jacobsens Allé 15, 2300 Copenhagen S, Denmark – Hub2 Auditorium

 

SIGN UP

Program

8:30 Networking, registration and light breakfast
9:00 Welcome and introduction to Medicon Valley Alliance
David Munis Zepernick, Director, Member Engagement & Communication, Medicon Valley Alliance
9:05 Welcome and Introduction to Fareva
Richa Foster-Jones, Area Sales Director DP
Thomas Pfeuffer, PhD, Business Development Manager API
 9:15 Innovative Approach to API Process Development
Thomas Pfeuffer, PhD, Business Development Manager API
9:30 A Successful Approach for Managing Unexpected Increases in Potency for HPAPIs
Thomas Pfeuffer, PhD, Business Development Manager API
9:45 Main consideration with high containment of solid oral dose up to OEB level 6
Richa Foster-Jones, Area Sales Director DP
10:00 Shortening the speed to market with one stop shop model at FAREVA
Richa Foster-Jones, Area Sales Director DP
10:15 Q&A Session
10:30 Networking
11:00 End of Good Morning Meeting

 

Speakers​​

  Richa Foster-Jones, Area Sales Director DP
Richa Foster-Jones is the Area Sales Director at FAREVA for Drug Product (DP) services covering UK, IR & Nordics. She has a good mix of science and business background with master’s in biotechnology from India and MBA from Dundee, Scotland which enables her to understand and communicate technical & business aspects of the solutions to her clients and partners.
She has over 15 years of experience working in the pharmaceutical and Biotech space giving her a good understanding of different phases of drug development and commercial launch.
 
Thomas Pfeuffer, PhD, Business Development Manager API
Dr. Thomas Pfeuffer (PhD) is Business Development Manager API at FAREVA Excella. After receiving his degree in pharmaceutical chemistry from the university of Wuerzburg, he started working for Excella GmbH & Co KG in 2010. There, he was responsible for cleaning and process validation, giving him a good insight in development, chemical production and GMP procedures. Later he was accountable for project management API for CDMO customers before moving to the sales team. The experience gained from various positions helps him to understand the customers’ needs and enables him to develop tailor-made solutions.
 

 

Organized by In collaboration with